Литература. 
Метаболический сердечно-сосудистый синдром

диабет инсулинорезистентность глюкоза ожирение.

• 1. Алмазов В. А., Благосклонная Я. В., Шляхто Е. В., Красильникова Е. И., Жукова А. В. Синдром инсулинорезистентности // Артериальная гипертензия.-1997.-Т.3,N1.-С.7−17.
• 2. Алмазов В. А., Благосклонная Я. В., Шляхто Е. В., Красильникова Е. И. Метаболический сердечно-сосудистый синдром.-СПб.:Изд-во СПбГМУ, 1999.-208 с.
• 3. Нагорнев В. А., Анестиади В. Х., Зота Е. Г. Атерогенез и иммунное воспаление.- М., 1997.-325 с.
• 4. Стаут Р. Инсулин и атеросклероз / В кн.:Гормоны и атеросклероз.-1985.-С.85−95.
• 5. Abate N., Garg A., Peshock R.M. et al. Relationship of generalizad and regional adiposity to insulin sensitivity in men //

J. Clin. Invest.-1995.-Vol.96.-P.88−98.

• 6. Agata J., Masuda A., Takada M. et al. High plasma immunoreactive leptin level in essential hypertension // Am.J.Hypertens.-1997.-Vol.10.-P.1171−1174.
• 7. Arrieta F., Rodriguez E., Ramos F. et al. Body mass index influence in the insulin action mechanisms comments // Ann.Med.Intrna.-1998.-Vol.15.-P.406−410.
• 8. Bjorntorp P. Endocrine abnormalities in obesity // Diabetes Rev.-1997.-Vol.5.-P.52−68.
• 9. Bray G.A., Greenway F.L. Current and Potential Drugs for Treatment of Obesity // Endocrine Rev.-1999.-Vol.20,N6.-P.805−875.
• 10. Crawford L., Anber V., McConnell M. et al. VLDL subfraction metabolism during alimentary lipemia // Atherosclerosis.-1997.-Vol.134 (Suppl.1,2).-P.337 (Abstr.).
• 11. Davi G., Gresele P., Violi F. et al. Diabetes mellitus, hypercholesterolemia and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo // Circulation.-1997.-Vol.96.-P.69−75.
• 12. Feinleib M. Epidemiology of obesity in relation to health hazards // Ann.Intern.Med.-1985.-Vol.103.-P.1019−1024.
• 13. Fernandez-Real J., Richard W., Casamitjana R. Lower Cortisol level after oral glucose in subjects with insulin resistance and abdominal obesity // Clin.Endocrinol.-1997.-Vol.47.-P.583−588.
• 14. Ferrannini E., Natali A., Bell P. et al. Insulin resistance and hypersecretion in obesity // J.Clin.Invest.- 1997. Vol. 100.-P.1166−1173.
• 15. Fracchini F., Chen Y.-D., Hollenbeck C.B. et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uzic acid ckearance and plasma uric acid concentration //JAMA.-1991.-Vol.266.-P.3008−3011.
• 16. Gertler M.M., Garn S.M., Levine S.A. Serum uric acid in relation to age and physique in health and coronary heart disease // Ann.Intern.Med.-1951.-Vol.34.-P.1421−1431.
• 17. Goodpaster B.H., Thaete F.L., Simoneau J.-L. et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat // Diabetes.-1997.-Vol.46.-P.1579−1585.
• 18. Hennes M., Dua A., Kisselbah A. Effects of free fatty acid and glucose on splanchnic insulin dynamics // Diabetes.-1997. -Vol.46.-P.57−62.
• 19. Jarrett R. In defence of insulin: a critique of Syndrom X // Lancet.-1992.-Vol.340.-P.469−483.
• 20. Jones P., Davy K., Alexander S. Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity// Am.J.Physiol.-1997.-Vol.20.-P.E976-E980.
• 21. Juhan-Wague I. PA-1 and risk of cardiovascular disease //In: 4th Int.Symp. on Multiple Risk Factors in Cardiovascul. Dis.-Washington, 1997.-P.5 (Abstr.).
• 22. Kalra S.P., Dube M.G., Pu S. et al. Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight// Endocrine Rew.-1999.-Vol.20,N1.-P.68−100.
• 23. Lesag S., Velho G., Vionnet N. et al. Genetic studies of the renin-angiotensin system in arterial hypertension, associated with non-insulin-dependent diabetes mellitus //J.Hypertens.-1997.-Vol.15.-P.601−606.
• 24. Matthaei S., Stumvoll M., Kellerer M. et al. Pathophysiology and Pharmacological Treatment of Insulin Resistance // Endocrine Rev.-1999.-Vol.21,N6.-P.585−618.
• 25. Miele C., Formisano P., Condorelli G. et al. Abnormal glucose transport and GLUT1 cell surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects //Diabetologia.-1997.-Vol.40.-P.421−429.
• 26. Olefsky J., Reaven G. Insulin binding in diabetes relationship with plasma insulin level and insulin sensitivity // Diabetes.-1997.-Vol.26.-P.680−688.
• 27. Pyorale K., Leakso M., Censitupia M. Diabetes and atherosclerosis: an epidemiological view // Diabetes Metab. Rev.-1987.-Vol.3.-P.463−524.
• 28. Reaven G.M., Hollenbeck C.B., Chen Y.-D. Relationship between glucose tolerance, insulin secretion and insulin action in nonobese individuals with varying degrees of glucose tolerance //Diabetology.-1989.-Vol.32.-P.52−55.
• 29. Reaven G.M. Role of insulin resistance in human disease: syndrom X // In: 4th Int.Symp. on Multiple Risk Factors in Cardiovascul. Dis.-Washington, 1997.-P.11 (Abstr.).
• 30. RichesF., Moroz P., Watts G. Meta-analysis of stable isotope studies of very-low-density lipoprotein apolipoprotein B-100 metabolism: effect of age, sex, body mass index and prandial status // Atherosclerosis.-1997.-Vol.134 (Suppl.1,2).-P.334 (Abstr.).
• 31. Shimamoto K., Kirata A., Masatoda F. et al. Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive pations // Hypertension.-1994.-Vol.23.-P.129−136.
• 32. Tschoepe D. Diabetes // In: 4th Int.Symp. on Multiple Risk Factors in Cardiovascul. Dis.-Washington, 1997.-P.25 (Abstr.).
• 33. Wajchenberg B.L. Subcutaneous and Visceral Adipose Tissue: Their Regulation to the Metabolic Syndrome // Endocrine Rew.-2000.-Vol.21,N6.-P.697−738.